Thompson Travis Alvin 4

What Happened

• Travis Alvin Thompson, Chief Financial Officer of Bicycle Therapeutics plc (BCYC), sold a total of 901 shares in two open-market transactions to satisfy tax-withholding obligations tied to RSU vesting. The sales consisted of 799 shares on 2026-04-02 at a weighted average price of $4.91 (proceeds ~$3,923) and 102 shares on 2026-04-06 at $5.05 (proceeds ~$515), for total proceeds of approximately $4,438. These were sell transactions (routine sell-to-cover), not purchases.

Key Details

• Transaction dates and prices:
  • 2026-04-02: 799 shares, weighted average $4.91 (component prices ranged $4.88–$4.98) — proceeds ~$3,923. (Footnote F2)
  • 2026-04-06: 102 shares at $5.05 — proceeds ~$515.
• Total shares sold: 901; total proceeds: approx. $4,438.
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Notable footnotes:
  • F1: Sales were mandated "sell-to-cover" to satisfy statutory tax withholding on RSU settlement (not discretionary sales by the reporting person).
  • F2: The 4/02 price is a weighted average; per-price breakdown is available from the filer or SEC staff on request.
• Filing: Report filed 2026-04-06 covering transactions on 2026-04-02 and 2026-04-06 (filing date shown in the SEC record).

Context

• "Sell-to-cover" transactions are common when restricted stock units vest; they are used solely to meet tax withholding requirements and generally do not signal an exec's view on the company's prospects. Purchases or open-market acquisitions are typically more informative about insider sentiment than mandatory tax-withholding sales.